- Home
- ACXP vs GROW Comparison
ACXP vs GROW Comparison
Compare ACXP & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACXP | GROW |
|---|---|---|
| Founded | 2017 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 32.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACXP | GROW |
|---|---|---|
| Price | $3.94 | $2.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $143.67 | N/A |
| AVG Volume (30 Days) | ★ 66.4K | 41.2K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 3.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $8,546,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $37.34 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.75 | $2.02 |
| 52 Week High | $26.60 | $2.78 |
Technical Indicators
Market Signals| Indicator | ACXP | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 37.39 | 51.87 |
| Support Level | $3.75 | $2.24 |
| Resistance Level | $4.48 | $2.33 |
| Average True Range (ATR) | 0.41 | 0.10 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 6.37 | 62.86 |
Price Performance
Historical ComparisonAbout ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.